HomeInsightsEPS

Aurobindo Pharma Ltd EPS

Aurobindo Pharma Ltd EPS

stocks purchased

₹ 3.9 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

31.6 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Aurobindo Pharma Ltd

NSE: AUROPHARMA

EPS

₹ 62.24

Last updated on: Dec 20, 2024

Key Highlights

  • The Earning per Share of Aurobindo Pharma Ltd is ₹ 62.24 as of 20 Dec 24 .
  • The earning per share of Aurobindo Pharma Ltd changed from ₹ 8.88 to ₹ 14 over 10 quarters. This represents a CAGR of 19.97% .

Historical Earning per Share of Aurobindo Pharma Ltd

No data available

* All values are in

Company Fundamentals for Aurobindo Pharma Ltd

Market Cap

72,697 Cr

EPS

62.2

P/E Ratio (TTM) *

19.9

P/B Ratio (TTM) *

2.3

Day’s High *

1274.7

Day’s Low

1235.15

DTE *

0.3

ROE *

11.6

52 Week High

1592.55

52 Week Low

959.05

ROCE *

13.7

Market Price of Aurobindo Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Aurobindo Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20241240.7
19 Dec 20241255.4
18 Dec 20241247.85
17 Dec 20241213.45
16 Dec 20241245
13 Dec 20241207.95
12 Dec 20241215.15
11 Dec 20241225.7
10 Dec 20241238.05
09 Dec 20241239.4

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Aurobindo Pharma Ltd

Market Value

72,697

Asset Value

25,059

1.9 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Aurobindo Pharma Ltd6272,697
Sun Pharmaceuticals Industries Ltd464,33,920
Divis Laboratories Ltd691,55,160
Cipla Ltd571,18,917
Torrent Pharmaceuticals Ltd511,16,225
Mankind Pharma Ltd521,12,324

Historical Market Cap of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Aurobindo Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Aurobindo Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Aurobindo Pharma Ltd News Hub

News

Auro Pharma gets UK MHRA nod for cancer drug

Bevqolva 25 mg/mL concentrate for infusion will be available in 4 mL (100 mg) and 16 mL (4...

Read more

21 Dec 2024 15:20

News

Auro Pharma's Telangana unit gets 2 USFDA observations

The United States Food and Drug Administration (US FDA) inspected Unit-V, an API manufactu...

Read more

18 Dec 2024 11:17

News

Apitoria Pharma's Unit V completes USFDA inspection

Aurobindo Pharma announced that the United States Food and Drug Administration (US FDA) in...

Read more

17 Dec 2024 19:55

News

Aurobindo Pharma arm receives positive opinion from EMA for Zefylti

The CHMP has recommended the granting of marketing authorization for Zefylti, which is int...

Read more

14 Dec 2024 16:18

News

Aurobindo Pharma Ltd drops for fifth straight session

Aurobindo Pharma Ltd fell for a fifth straight session today. The stock is quoting at Rs 1...

Read more

13 Dec 2024 13:35

News

CuraTeQ Biologics received recommendation of a marketing authorisation for Zefylti

CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma,  announced that the Comm...

Read more

13 Dec 2024 18:31

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2023

TranscriptPPT

June 2022

TranscriptPPT

Aug 2021

PPT

June 2021

TranscriptPPT

June 2020

TranscriptPPT

Jan 2020

PPT

FAQs for EPS of Aurobindo Pharma Ltd

What is the EPS of Aurobindo Pharma Ltd stock?

The Earnings Per Share (EPS) of Aurobindo Pharma Ltd is 62.24. An EPS is the amount of net income attributed to each share of a common stock.

How is Aurobindo Pharma Ltd EPS calculated?

The EPS of Aurobindo Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Aurobindo Pharma Ltd report its EPS?

Aurobindo Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Aurobindo Pharma Ltd EPS?

Factors that influence the EPS of Aurobindo Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Aurobindo Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Aurobindo Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions